Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Daily News

Percutaneous LVADs Can Spur Aortic Regurgitation, Small Study Cautions

L.A. McKeown

October 14, 2025

News Conference News SCAI 2025

When Early Cardiogenic Shock Isn’t Dealt With, Outcomes Can Suffer

L.A. McKeown

May 09, 2025

News Conference News PCR London Valves 2023

Acute Decompensated Aortic Stenosis: Time for an Urgent TAVI Pathway?

Shelley Wood

November 20, 2023

News Daily News

Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients

Caitlin E. Cox

December 09, 2022

News Daily News

US Claims Data Point to Better Survival With Impella vs IABP in High-Risk PCI

Caitlin E. Cox

October 20, 2022

News Daily News

FDA: New Fix Available for Medtronic’s Troubled HeartWare VADs

Michael O'Riordan

October 17, 2022

News Daily News

Longer-Term Data Still Worrisome for Impella-Treated AMICS Patients

Caitlin E. Cox

July 20, 2022

News Conference News THT 2022

Cardiogenic Shock’s Origins, Progression Tightly Tied to Mortality

Caitlin E. Cox

February 07, 2022

News Daily News

Shock in COVID-19: Types, Triggers, and Treatments Differ, but Outlook Is Grim

Caitlin E. Cox

November 24, 2021

News Daily News

MitraClip Viable in Shock Patients With Significant MR: Observational Study

Michael O'Riordan

July 29, 2021

News Daily News

Fivefold Increase in Impella Use for Cardiogenic Shock in Acute MI: US Data

Caitlin E. Cox

July 06, 2021

News Conference News AHA 2018

Study Lays Groundwork for Pivotal Trial of Impella CP for LV Unloading Before PCI

Todd Neale

November 11, 2018

News Conference News ACC 2018

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Shelley Wood

March 05, 2018

News Daily News

Study Finds Exponential Growth in Percutaneous LVAD Use

April 08, 2015

News Daily News

Mortality, Hospital Costs Drop as Short-term Mechanical Circulatory Support Use Grows

November 02, 2014

News Conference News ESC 2013

TASTE: No Appetite for Manual Thrombus Aspiration

September 01, 2013

Advertisement

Percutaneous LVADs Can Spur Aortic Regurgitation, Small Study Cautions

When Early Cardiogenic Shock Isn’t Dealt With, Outcomes Can Suffer

Acute Decompensated Aortic Stenosis: Time for an Urgent TAVI Pathway?

Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients

US Claims Data Point to Better Survival With Impella vs IABP in High-Risk PCI

FDA: New Fix Available for Medtronic’s Troubled HeartWare VADs

Longer-Term Data Still Worrisome for Impella-Treated AMICS Patients

Cardiogenic Shock’s Origins, Progression Tightly Tied to Mortality

Shock in COVID-19: Types, Triggers, and Treatments Differ, but Outlook Is Grim

MitraClip Viable in Shock Patients With Significant MR: Observational Study

Fivefold Increase in Impella Use for Cardiogenic Shock in Acute MI: US Data

Study Lays Groundwork for Pivotal Trial of Impella CP for LV Unloading Before PCI

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Study Finds Exponential Growth in Percutaneous LVAD Use

Mortality, Hospital Costs Drop as Short-term Mechanical Circulatory Support Use Grows

TASTE: No Appetite for Manual Thrombus Aspiration

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content